Wednesday, May 7, 2025 — A customer from Iraq recently arrived at Wixbio’s manufacturing facility in China for a fruitful visit and exchange. The purpose of the visit was to gain insights and training on products already registered and sold in the Iraqi market, including the inactivated avian influenza (H5+H9) vaccine, the ND-AI-IBH vaccine, the adenovirus vaccine, and the ND & AI Reassortant Virus Vaccine, among others.
During the several-day visit, the Iraqi customer and Wixbio’s technical team discussed key topics such as strain matching, testing methods, and immunization procedures. The two sides exchanged ideas and shared their experiences and technical insights to improve the local application of these products and better serve the needs of the Iraqi market.
Specifically, the discussions focused on the following areas:
Strain Matching: Based on the characteristics of the pathogens in the region, discussions were held on selecting the most suitable vaccine strains to ensure optimal vaccine protection.
Testing methods: Introduction and training on the latest laboratory testing techniques for more accurate vaccine efficacy and disease surveillance assessment.
Immunization procedures: To achieve the best preventive effect, optimal immunization schedules for different types of poultry and local breeding environments must be developed.
This face-to-face interaction strengthened the relationship between the two parties and laid the foundation for further expansion of the cooperation area. Wixbio said it will continue to be committed to providing high-quality animal healthcare solutions to its global customers and hopes that such interactions will help more farmers prevent and control diseases effectively and promote the healthy development of the animal husbandry industry.
